MEMBER'S LOGINX
| Invalid Username / Password | ||||||||
| Invalid Captcha | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
India's Third Giant Leap
This Could be One of the Biggest Opportunities for Investors
- Home
- Todays Market
- Indian Stock Market News January 21, 2020
Sensex Ends 205 Points Lower; Power and Realty Stocks Witness Selling Tue, 21 Jan Closing
Editor's note: Dear reader, we are now on Telegram! Get our latest views on stock markets and more, instantly. Join our Telegram channel here!
India share markets continued to witness selling pressure during closing hours and ended their day on a negative note.
At the closing bell, the BSE Sensex stood lower by 205 points (down 0.5%) and the NSE Nifty stood down by 54 points (down 0.5%).
The BSE Mid Cap index ended the day down 0.2%, while the BSE Small Cap index stood flat.
Stocks in the power sector and realty sector witnessed huge selling pressure, while telecom stocks were trading in the green.
The rupee was trading at 71.16 against the US$.
Asian stock markets finished on a negative note. As of the most recent closing prices, the Hang Seng was down by 2.81% and the Shanghai Composite was down by 1.41%. The Nikkei 225 was down 0.91%.
European markets were also trading on a negative note. The FTSE 100 was down by 1.25%. The DAX was trading down by 0.46%, while the CAC 40 stood down 1.11%.
Speaking of the Indian economy and Indian share markets, Ankit wrote to you about a recent upcoming IPO. It's a company profiting from two megatrends - digitisation and financialisation - in the Indian economy.
Have a look at the chart below. A quick comparison of assets under management (AUM) of mutual funds in India versus abroad will give you a clear idea of the huge megatrend.
Mutual Funds: Megatrend of the decade?
India's mutual fund AUM as a percentage of GDP is 11%. This is far lower than the world average of 55%.
Here's what Tanushree Banerjee wrote about it in a recent edition of The 5 Minute WrapUp...
- I strongly believe, the next decade could be the decade of financialisation in India.
Traditionally, Indian households have preferred to invest in physical assets like real estate but things are changing.
Indians now are more open to investing in financial assets like mutual funds. Better awareness, financial education, increasing urbanisation are all driving this change.
Mutual fund AUM grew 24% annually in the last 5 years. I expect India's GDP to grow at 6-7% over the next decade.
Just combine these growth rates and you can see the massive growth opportunity.
Tanushree has also shared a popular video of Vijay Bhambwani along with the full transcript, on safe investments for 2020.
You can check out the same here: Your Safe Income Options for 2020
In news from the pharma sector, Alembic Pharmaceuticals share price was in focus today as the US health regulator conducted an inspection at its facility in Karkhadi, Gujarat.
The company in a filing said that the US Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals active pharmaceutical ingredient (API) facility located at Karkhadi from January 13 to January 17, 2020.
At the end of the inspection, the USFDA issued a form 483 with two observations.
This was a scheduled pre-approval inspection.
Note that the US Food and Drug Administration (USFDA) is back in action again as at least five companies filed corporate announcements on the stock exchanges related to the health regulator over the past three days.
Cipla announced the closure of inspection by the USFDA at its Patalganga manufacturing facility in Maharashtra.
Biocon also informed bourses that pre-approval inspection of the Bengaluru facility of its arm conducted by US health regulator was concluded with zero observations.
Strides Pharma Science (Strides) said its arm has received an establishment inspection Report (EIR) from the US health regulator for its Florida facility in the US. Strides Pharma Inc received EIR from the USFDA for the inspection conducted at its unit it December last year.
Drug major Lupin on Saturday said it has received five observations from the US health regulator after inspection of its Vizag facility in Andhra Pradesh.
And SMS Pharma today informed exchanges that the United States Food and Drug Administration (USFDA) conducted a cGMP inspection at Kandivalasa, Vipanagaram, Andhra Pradesh API manufacturing facility from January 13-17.
How this trend pans out in the coming days and what effect it will have on the pharma sector remains to be seen. We will keep you updated on all the developments from this space.
Speaking of the pharma sector, in the video below, Tanushree talks in great detail about where the sector stands now and also about its potential for a rebound.
Tune in to find out more...
Moving on to news from the banking sector, Federal Bank share price was in focus today as the bank's third quarter net profit rose 32% year-on-year (YoY) on the back of higher other income and lower provision.
The bank posted a net profit Rs 4.4 billion for the three months ended 31 December compared to Rs 3.3 billion in the year-ago period.
Net interest income, or the difference between interest earned on loans and that paid on deposits, increased 7.21% YoY to Rs 11.5 billion from Rs 10.7 billion in the corresponding period last year.
Other income, which includes core fee income, rose 18.03% to Rs 4 billion in the three months from Rs 3.4 billion a year ago.
Gross non-performing assets (NPAs), as a percentage of total advances, were at 2.99% in the December quarter compared with 3.07% in the September quarter and 3.14% in the year-ago December quarter.
Provisions during the quarter decreased 15.39% to Rs 1.6 billion as against Rs 1.9 billion in the year-ago quarter. In the July-September quarter, the bank had set aside Rs 2.5 billion in provisions.
Post-provision, the net NPA ratio was at 1.63% against 1.59% in the July-September quarter and 1.72% in the year-ago quarter.
To know more, you can read Federal Bank's Q3FY20 result analysis on our website.
And to know what's moving the Indian stock markets today, check out the most recent share market updates here.
For information on how to pick stocks that have the potential to deliver big returns, download our special report now!
Read the latest Market Commentary
Indian Share Market Update: Top Gainers and Losers
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
- Multibagger Penny Stocks
- Basics of Value Investing
- Benjamin Graham
- How to Invest in Gold
- How to Invest in Silver
- Best Stocks to Buy Today
- Best Small-cap Stocks to Buy
- Best Bluechip Stocks to Buy
- Guide to Penny Stocks
- How to Invest in the Share Market
- Warren Buffett - The Value Investor
- Pick the Best Multibagger Stocks
TRENDING TOPICS
Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407
Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com
LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
Equitymaster requests your view! Post a comment on "Sensex Ends 205 Points Lower; Power and Realty Stocks Witness Selling". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!